Jeffrey Chodakewitz
Board Member
Adicet Bio, Inc. (ACET)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey Chodakewitz
Jeffrey Chodakewitz is recorded as Board Member at Adicet Bio, Inc. (ACET). Jeffrey Chodakewitz was last confirmed as Board Member at Praxis Precision Medicines, Inc. (PRAX) in a filing dated April 30, 2025. Adicet Bio, Inc. reported in an 8-K filed June 5, 2023 that Jeffrey Chodakewitz was appointed Class II director, effective June 1, 2023.
“The stockholders of the Company elected Carl L. Gordon, Ph.D., Steve Dubin, and Jeffrey Chodakewitz, M.D. as Class II directors of the Company, for a three-year term ending at the annual meeting of stockholders to be held in 2026 and until their successors have been duly elected and qualified or until their earlier resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-09-15–present
-
2021-01-01–2025-04-30
Last confirmed by a filing; no departure on record
-
2020-01-01–2020-09-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Adicet Bio, Inc.
Other people whose current roles at this company are on record from its filings.
- Chen Schor CEO
- Nick Harvey CFO
- Stewart Abbot COO
- Stewart Abbot, Ph.D. COO
- Don Healey, Ph.D. CTO
- Donald Healey CTO
- Lloyd Klickstein CIO
- Andrew Sinclair, Ph.D. Board Member
- Carl Gordon Board Member
- Carl L. Gordon Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.